What are the lipid highlights from ACC.22?
In this insightful review, Dr Erin Michos (Johns Hopkins University School of Medicine, Baltimore, MD, US) talks about selected ACC.22 late-breaking clinical trials highlighting the take-home messages for clinical practice.
Trials covered in detail include:
00:28: APOLLO Trial: Magnitude and Duration of Effects of a Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial
01:56: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients With Acute Myocardial Infarction: A Double-blind, Placebo-controlled, Randomized Trial
3:29: TRANSLATE-TIMI 70: Effect of Vupanorsen on Non-high-density Lipoprotein Cholesterol Levels In Statin-treated Patients With Elevated Cholesterol
05:05: SuperWIN: A Multisite, Randomized, Controlled Trial of a Supermarket and Web-based Intervention Targeting Nutrition For Cardiovascular Risk Reduction
Recorded on-site at ACC.22, Washington DC.